Haynes BF - Search Results

1

HIV-Host Interactions: Implications for Vaccine Design.

Haynes BF, Shaw GM, Korber B, Kelsoe G, Sodroski J, Hahn BH, Borrow P, McMichael AJ. Haynes BF, et al. Cell Host Microbe. 2016 Mar 9;19(3):292-303. doi: 10.1016/j.chom.2016.02.002. Epub 2016 Feb 25. Cell Host Microbe. 2016. PMID: 26922989 Free PMC article. Review.

2

HIV type 1 V3 region primer-induced antibody suppression is overcome by administration of C4-V3 peptides as a polyvalent immunogen.

Haynes BF, Moody MA, Heinley CS, Korber B, Millard WA, Scearce RM. Haynes BF, et al. AIDS Res Hum Retroviruses. 1995 Feb;11(2):211-21. doi: 10.1089/aid.1995.11.211. AIDS Res Hum Retroviruses. 1995. PMID: 7742036

3

Toward an understanding of the correlates of protective immunity to HIV infection.

Haynes BF, Pantaleo G, Fauci AS. Haynes BF, et al. Science. 1996 Jan 19;271(5247):324-8. doi: 10.1126/science.271.5247.324. Science. 1996. PMID: 8553066 Review.

4

HIV vaccines: where we are and where we are going.

Haynes BF. Haynes BF. Lancet. 1996 Oct 5;348(9032):933-7. doi: 10.1016/S0140-6736(96)09339-7. Lancet. 1996. PMID: 8843815 Review.

5

Update on the issues of HIV vaccine development.

Haynes BF, Putman SB, Weinberg JB. Haynes BF, et al. Ann Med. 1996 Feb;28(1):39-41. doi: 10.3109/07853899608999072. Ann Med. 1996. PMID: 8932504 Free article.

6

Induction of antibodies in guinea pigs and rhesus monkeys against the human immunodeficiency virus type 1 envelope: neutralization of nonpathogenic and pathogenic primary isolate simian/human immunodeficiency virus strains.

Liao HX, Etemad-Moghadam B, Montefiori DC, Sun Y, Sodroski J, Scearce RM, Doms RW, Thomasch JR, Robinson S, Letvin NL, Haynes BF. Liao HX, et al. Among authors: haynes bf. J Virol. 2000 Jan;74(1):254-63. doi: 10.1128/jvi.74.1.254-263.2000. J Virol. 2000. PMID: 10590113 Free PMC article.

7

Medicine. The need for a global HIV vaccine enterprise.

Klausner RD, Fauci AS, Corey L, Nabel GJ, Gayle H, Berkley S, Haynes BF, Baltimore D, Collins C, Douglas RG, Esparza J, Francis DP, Ganguly NK, Gerberding JL, Johnston MI, Kazatchkine MD, McMichael AJ, Makgoba MW, Pantaleo G, Piot P, Shao Y, Tramont E, Varmus H, Wasserheit JN. Klausner RD, et al. Among authors: haynes bf. Science. 2003 Jun 27;300(5628):2036-9. doi: 10.1126/science.1086916. Science. 2003. PMID: 12829768

8

Centralized immunogens as a vaccine strategy to overcome HIV-1 diversity.

Gao F, Korber BT, Weaver E, Liao HX, Hahn BH, Haynes BF. Gao F, et al. Among authors: haynes bf. Expert Rev Vaccines. 2004 Aug;3(4 Suppl):S161-8. doi: 10.1586/14760584.3.4.s161. Expert Rev Vaccines. 2004. PMID: 15285714 Free article. Review.

9

Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group m consensus envelope glycoprotein.

Gao F, Weaver EA, Lu Z, Li Y, Liao HX, Ma B, Alam SM, Scearce RM, Sutherland LL, Yu JS, Decker JM, Shaw GM, Montefiori DC, Korber BT, Hahn BH, Haynes BF. Gao F, et al. Among authors: haynes bf. J Virol. 2005 Jan;79(2):1154-63. doi: 10.1128/JVI.79.2.1154-1163.2005. J Virol. 2005. PMID: 15613343 Free PMC article.

10

Analysis of HIV-1 subtype B third variable region peptide motifs for induction of neutralizing antibodies against HIV-1 primary isolates.

Haynes BF, Ma B, Montefiori DC, Wrin T, Petropoulos CJ, Sutherland LL, Scearce RM, Denton C, Xia SM, Korber BT, Liao HX. Haynes BF, et al. Virology. 2006 Feb 5;345(1):44-55. doi: 10.1016/j.virol.2005.08.042. Epub 2005 Oct 20. Virology. 2006. PMID: 16242749 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

783 results

Search Page

Filters